Evidence map›Paper›PMID 33637798›Full record

ArticleScientific reports2021

HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada.

Yoojin Choi, Mona Loutfy, Robert S Remis, Juan Liu, Anuradha Rebbapragada, Sanja Huibner, Jason Brunetta, Graham Smith, Tatjana Reko, Roberta Halpenny and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Yoojin ChoiDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada. yoojinc.choi@mail.utoronto.ca.
Mona LoutfyDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Robert S RemisDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Juan LiuPublic Health Laboratory-Toronto, Public Health Ontario, Toronto, Ontario, Canada.
Anuradha RebbapragadaCanada HealthLabs, Toronto, Ontario, Canada.
Sanja HuibnerDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Jason BrunettaMaple Leaf Medical Clinic, Toronto, Ontario, Canada.
Graham SmithMaple Leaf Medical Clinic, Toronto, Ontario, Canada.
Tatjana RekoGlaxoSmithKline, Mississauga, Ontario, Canada.
Roberta HalpennyMaple Leaf Medical Clinic, Toronto, Ontario, Canada.
Rupert KaulDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Troy GrennanBC Centre for Disease Control, Vancouver, British Columbia, Canada.
University of Toronto · CAMaple Leaf Medical Clinic · CAToronto Public Health · CAGlaxoSmithKline (Canada) · CAUniversity Health Network · CAUniversity of British Columbia · CA

Funding

CIHR HET-85518CIHR TE2-138200
6 · The paper itself

Abstract

Men who have sex with men (MSM) are disproportionately affected by anal cancer, predominantly caused by high-risk (HR) human papillomavirus (HPV) infection. Currently, the nonavalent HPV vaccine provides coverage against nine HPV genotypes, including seven HR-HPV genotypes. Here, we characterize anal HR-HPV genotype distribution and associated risk factors in MSM from Toronto, Canada recruited between September 2010 and June 2012. Wilcoxon-Mann-Whitney test was used for continuous variables, Chi-square test was performed for categorical variables, and a multivariable model using logistic regression was created to assess for correlates of anal HR-HPV infection. A total of 442 MSM were recruited, with a median age of 45 (IQR 38-50) and an overall HPV prevalence of 82%. The prevalence of any HR-HPV infection was 65.3% and 50.7% in the HIV-positive and HIV-negative MSM, respectively. No participant tested positive for all genotypes covered by the nonavalent vaccine. HIV status (aOR 1.806; 95% CI 1.159-2.816), smoking (aOR 2.176; 95% CI 1.285-3.685) and the number of lifetime sexual partners (aOR 2.466; 95% CI 1.092-5.567) were independent risk factors for anal HR-HPV infection. Our findings will be useful to inform HPV vaccine rollout and HPV prevention strategies in Canadian MSM.

Indexed as

AdultAlphapapillomavirusAnal CanalAnus DiseasesCanadaGenotypeHomosexuality, MaleHumansMaleMiddle AgedPapillomavirus InfectionsRisk FactorsSexual Partners

Identifiers

PMID33637798
PMCPMC7910431
OpenAlexW3129363259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.